Display options
Share it on

Int J Nephrol. 2012;2012:748984. doi: 10.1155/2012/748984. Epub 2012 Sep 02.

Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association.

International journal of nephrology

Amy Rebecca Bentley, Ayo P Doumatey, Guanjie Chen, Hanxia Huang, Jie Zhou, Daniel Shriner, Congqing Jiang, Zhenjian Zhang, Guozheng Liu, Olufemi Fasanmade, Thomas Johnson, Johnnie Oli, Godfrey Okafor, Benjamin A Eghan, Kofi Agyenim-Boateng, Jokotade Adeleye, Williams Balogun, Clement Adebamowo, Albert Amoah, Joseph Acheampong, Adebowale Adeyemo, Charles N Rotimi

Affiliations

  1. Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-5635, USA.

PMID: 22973513 PMCID: PMC3438781 DOI: 10.1155/2012/748984

Abstract

Low levels of high-density cholesterol (HDLc) accompany chronic kidney disease, but the association between HDLc and the estimated glomerular filtration rate (eGFR) in the general population is unclear. We investigated the HDLc-eGFR association in nondiabetic Han Chinese (HC, n = 1100), West Africans (WA, n = 1497), and African Americans (AA, n = 1539). There were significant differences by ancestry: HDLc was positively associated with eGFR in HC (β = 0.13, P < 0.0001), but negatively associated among African ancestry populations (WA: -0.19, P < 0.0001; AA: -0.09, P = 0.02). These differences were also seen in nationally-representative NHANES data (among European Americans: 0.09, P = 0.005; among African Americans -0.14, P = 0.03). To further explore the findings in African ancestry populations, we investigated the role of an African ancestry-specific nephropathy risk variant, rs73885319, in the gene encoding HDL-associated APOL1. Among AA, an inverse HDLc-eGFR association was observed only with the risk genotype (-0.38 versus 0.001; P = 0.03). This interaction was not seen in WA. In summary, counter to expectation, an inverse HDLc-eGFR association was observed among those of African ancestry. Given the APOL1 × HDLc interaction among AA, genetic factors may contribute to this paradoxical association. Notably, these findings suggest that the unexplained mechanism by which APOL1 affects kidney-disease risk may involve HDLc.

References

  1. Heredity (Edinb). 2011 Oct;107(5):413-20 - PubMed
  2. Cardiovasc J Afr. 2010 May-Jun;21(3):148-52 - PubMed
  3. J Lipid Res. 2010 Jul;51(7):1982-90 - PubMed
  4. J Diabetes. 2010 Sep;2(3):180-93 - PubMed
  5. Am J Kidney Dis. 1993 Jul;22(1):72-82 - PubMed
  6. Arch Intern Med. 2008 Nov 10;168(20):2212-8 - PubMed
  7. Lancet. 2012 Aug 11;380(9841):572-80 - PubMed
  8. Kidney Int. 2011 Mar;79(5):555-62 - PubMed
  9. Am J Transplant. 2011 May;11(5):1025-30 - PubMed
  10. Diabetes Metab. 2010 Sep;36(4):278-85 - PubMed
  11. Am J Clin Nutr. 2010 Oct;92(4):897-904 - PubMed
  12. Ann Epidemiol. 2001 Jan;11(1):51-8 - PubMed
  13. Metabolism. 1996 Mar;45(3):328-33 - PubMed
  14. Curr Diab Rep. 2010 Jun;10(3):199-208 - PubMed
  15. Science. 2010 Aug 13;329(5993):841-5 - PubMed
  16. Kidney Int. 2000 Jul;58(1):293-301 - PubMed
  17. Am J Nephrol. 2004 Jan-Feb;24(1):46-53 - PubMed
  18. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16928-33 - PubMed
  19. Am J Nephrol. 2008;28(5):723-31 - PubMed
  20. Metabolism. 2006 Jan;55(1):96-102 - PubMed
  21. Kidney Int. 2007 Jan;71(2):159-66 - PubMed
  22. Hypertension. 1995 Oct;26(4):670-5 - PubMed
  23. J Am Soc Nephrol. 2002 Sep;13(9):2363-70 - PubMed
  24. Ann Intern Med. 1999 Mar 16;130(6):461-70 - PubMed
  25. Circulation. 2010 Feb 23;121(7):e46-e215 - PubMed
  26. J Am Soc Nephrol. 2010 Sep;21(9):1422-6 - PubMed
  27. J Am Soc Nephrol. 2003 Nov;14(11):2902-7 - PubMed
  28. J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S145-7 - PubMed
  29. Adv Chronic Kidney Dis. 2008 Apr;15(2):147-52 - PubMed
  30. Nephrol Dial Transplant. 2011 Nov;26(11):3805-10 - PubMed
  31. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
  32. PLoS Genet. 2009 Jul;5(7):e1000564 - PubMed
  33. Horm Metab Res. 2009 Feb;41(2):79-85 - PubMed
  34. J Pediatr. 2009 Sep;155(3):S7.e7-11 - PubMed
  35. Kidney Int. 2002 Oct;62(4):1402-7 - PubMed
  36. Curr Atheroscler Rep. 2005 Nov;7(6):472-9 - PubMed
  37. Atherosclerosis. 2004 Oct;176(2):371-7 - PubMed
  38. Kidney Int. 2011 Jan;79(1):99-111 - PubMed
  39. Kidney Int. 2005 May;67(5):1967-73 - PubMed
  40. Curr Opin Lipidol. 2009 Aug;20(4):293-9 - PubMed
  41. J Clin Lipidol. 2008 Dec;2(6):410-7 - PubMed
  42. Ann Intern Med. 2009 May 5;150(9):604-12 - PubMed
  43. CVD Prev Control. 2010 Sep 1;5(3):75-80 - PubMed
  44. Clin J Am Soc Nephrol. 2008 Jan;3(1):125-32 - PubMed
  45. Am J Cardiol. 2010 Oct 1;106(7):969-75 - PubMed
  46. Obesity (Silver Spring). 2010 Aug;18(8):1638-45 - PubMed
  47. J Am Soc Nephrol. 2009 Dec;20(12):2617-24 - PubMed
  48. Nat Genet. 2006 Aug;38(8):904-9 - PubMed
  49. J Am Soc Nephrol. 2003 Aug;14(8):2084-2091 - PubMed
  50. Am J Clin Nutr. 2010 Sep;92(3):500-8 - PubMed
  51. Metabolism. 2009 Feb;58(2):212-9 - PubMed

Publication Types

Grant support